CYP3A7-CYP3A51P Gene

Name CYP3A7-CYP3A51P readthrough
Description This locus represents readthrough transcription between the neighboring CYP3A7 (cytochrome P450, family 3, subfamily A, polypeptide 7) and CYP3A51P (cytochrome P450, family 3, subfamily A, polypeptide 51, pseudogene) genes, which are members of the CYP3A gene cluster on chromosome 7. The downstream pseudogene is not known to be independently transcribed. The readthrough transcript includes CYP3A7 exons 1-13 and exons 2 and 13 of the pseudogene. It encodes a CYP3A isoform with a novel C-terminus. This isoform is only expressed in alleles containing a T nucleotide at the -6 position of a splice acceptor in the pseudogene, which enables correct splicing of the upstream CYP3A7 exons to the pseudogene exons. It should be noted that the reference genome sequence represents the CYP3A7_39256 T->A allele, and thus this haplotype is unlikely to produce the readthrough transcript. [provided by RefSeq, Jan 2015]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The CYP3A gene cluster encodes several enzymes with overlapping yet distinct roles in the metabolism of endogenous hormones and xenobiotics. In particular, CYP3A7 is best known as the predominant cytochrome P450 in the fetal liver, where it catalyzes the 16α‐hydroxylation of steroid hormones such as dehydroepiandrosterone sulfate and estrone and participates in retinoic acid clearance (see."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Although CYP3A7 is normally silenced after birth, a variant allele (CYP3A7*1C) confers persistent postnatal expression in a subset of individuals. This allele achieves its effect by replacing part of the CYP3A7 promoter with corresponding regulatory sequences from CYP3A4, thereby enhancing binding of nuclear receptors and transcription factors that support robust expression in liver and extrahepatic tissues such as the intestine and endometrium."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}, {"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In adults expressing CYP3A7, the enzyme may contribute a considerable fraction of total CYP3A content—up to 9–36% in some livers—and is implicated in modulating circulating steroid levels as well as influencing the metabolism of drugs. Although its intrinsic catalytic efficiency toward xenobiotic substrates is generally lower than that of CYP3A4, CYP3A7 appears to play a complementary role when the activities of other CYP3A members (for example, CYP3A4 and CYP3A5) are variable."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, coordinated regulation by hepatic transcription factors—including C/EBPα and HNF‐3 family members—suggests that CYP3A7 expression and its contribution to overall metabolic capacity is governed by complex developmental and tissue‐specific signals."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " \n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n The CYP3A7–CYP3A51P region is part of this intricate gene cluster. While CYP3A7 encodes a functional enzyme with significant roles in fetal steroid metabolism and, in selected adults, drug processing, CYP3A51P is regarded as a pseudogene that contributes structurally to the locus without producing a catalytically active protein."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n In summary, the functional importance of CYP3A7 lies in its developmental role in hormone metabolism and—in individuals carrying the CYP3A7*1C allele—in its persistent adult expression that can influence both endogenous steroid homeostasis and drug clearance. Understanding the regulation and variable expression of CYP3A7 is therefore critical for elucidating interindividual differences in both hormonal balance and pharmacokinetic responses.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Oliver Burk, Heike Tegude, Ina Koch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M202345200"}], "href": "https://doi.org/10.1074/jbc.M202345200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11940601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11940601"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Pauline Smit, Ron H N van Schaik, Marloes van der Werf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2005-0307"}], "href": "https://doi.org/10.1210/jc.2005-0307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15985487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15985487"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Sarah C Sim, Robert J Edwards, Alan R Boobis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.fpc.0000171516.84139.89"}], "href": "https://doi.org/10.1097/01.fpc.0000171516.84139.89"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16041241"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16041241"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mohamadi A Sarkar, Vijay Vadlamuri, Shobha Ghosh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Drug Metab Dispos (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/dmd.31.1.1"}], "href": "https://doi.org/10.1124/dmd.31.1.1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12485945"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12485945"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Beatrice Oneda, Severine Crettol, Evelyne Jaquenoud Sirot, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenet Genomics (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FPC.0b013e32833225e7"}], "href": "https://doi.org/10.1097/FPC.0b013e32833225e7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19801957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19801957"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Roberto Canaparo, Niklas Finnström, Loredana Serpe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Pharmacol Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1440-1681.2007.04691.x"}], "href": "https://doi.org/10.1111/j.1440-1681.2007.04691.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17880367"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17880367"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "C Rodríguez-Antona, R Bort, R Jover, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.63.5.1180"}], "href": "https://doi.org/10.1124/mol.63.5.1180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12695546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12695546"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Haixing Li, Jed N Lampe "}, {"type": "b", "children": [{"type": "t", "text": "Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2019.108078"}], "href": "https://doi.org/10.1016/j.abb.2019.108078"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31445893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31445893"}]}]}]}
Synonyms CYP3A7-CYP3AP1, CYP3A7.1L, CYP3A7-3AP1, CYP3A7
NCBI Gene ID 100861540
API
Download Associations
Predicted Functions View CYP3A7-CYP3A51P's ARCHS4 Predicted Functions.
Co-expressed Genes View CYP3A7-CYP3A51P's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View CYP3A7-CYP3A51P's ARCHS4 Predicted Functions.

Functional Associations

CYP3A7-CYP3A51P has 709 functional associations with biological entities spanning 6 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 29 datasets.

Click the + buttons to view associations for CYP3A7-CYP3A51P from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of CYP3A7-CYP3A51P gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of CYP3A7-CYP3A51P gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP3A7-CYP3A51P gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing CYP3A7-CYP3A51P protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with CYP3A7-CYP3A51P protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP3A7-CYP3A51P gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
DisGeNET Gene-Disease Associations diseases associated with CYP3A7-CYP3A51P gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of CYP3A7-CYP3A51P gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of CYP3A7-CYP3A51P gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GO Biological Process Annotations 2025 biological processes involving CYP3A7-CYP3A51P gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2025 cellular components containing CYP3A7-CYP3A51P protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by CYP3A7-CYP3A51P gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of CYP3A7-CYP3A51P gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with CYP3A7-CYP3A51P gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by CYP3A7-CYP3A51P gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for CYP3A7-CYP3A51P protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of CYP3A7-CYP3A51P gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
KEGG Pathways 2026 pathways involving CYP3A7-CYP3A51P protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of CYP3A7-CYP3A51P gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with CYP3A7-CYP3A51P gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by CYP3A7-CYP3A51P gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of CYP3A7-CYP3A51P gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MW Enzyme Metabolite Associations interacting metabolites for CYP3A7-CYP3A51P protein from the MW Gene Metabolite Associations dataset.
PFOCR Pathway Figure Associations 2024 pathways involving CYP3A7-CYP3A51P protein from the Wikipathways PFOCR 2024 dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of CYP3A7-CYP3A51P gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of CYP3A7-CYP3A51P gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of CYP3A7-CYP3A51P gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with CYP3A7-CYP3A51P protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving CYP3A7-CYP3A51P protein from the Wikipathways Pathways 2014 dataset.